FDA Investigator Amanda Dinaro
Amanda Dinaro has conducted inspections on 84 sites in 6 countries as of 17 Apr 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
17 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Israel,
Germany,
Hungary,
China,
Taiwan
FDA Investigators that have inspected at least one site in common with Amanda Dinaro:
Aaron L Dunbar,
Adaliz Santaliz Cruz,
Alicia M Mozzachio,
Althea A Williams,
Amanda S Zorn,
Ana L Kewes,
Anna Flynn,
Benjamin W Anderson,
Bonnie E Conley,
Bradley J Maunder,
Brian D Nicholson,
Brian P Emanuel,
Brittani N Franklin,
Bruce H Mccullough,
Bryan L Mcguckin,
Carl A Huffman, III,
Carlyn L Ray,
Carrie Ann Plucinski,
Catherine J Laufmann,
Chad E Schmear,
Chad J Whitwell,
Charles L Zhou,
Chiang Syin, PhD,
Christina A Miller,
Christina L Bigham,
Christine M Parmentier,
Claudette D Brooks,
Clotia Cabbey Mensah,
Constantin Y Philopoulos,
Corey K Reno,
Creighton T Tuzon,
Daniel B Arrecis,
Daniel C Kearns,
Daniel J Lahar,
Daniel Kearns,
Daniel L Aisen,
Danielle M Maddox,
Darrell E Luedtke,
David J Gasparovich,
Dawn M Braswell,
Debra I Love,
Debra Lboyd Seale,
Denise L Burosh,
Dolores Harper,
Donna D Gallien, MPH,
Donna K Speer,
Dorothy W Lee,
Dr. Guang Gao, PhD,
Edward E Lockwood (EEL),
Elizabeth L Holmes,
Elliot P Cowam, PhD,
Emma R Schaefer,
Eric C Fox,
Eric M Mueller, PharmD,
Eric S Pittman,
Francis A Guidry,
Frank J Marciniak,
Frederic W French, III,
Freed A Sharif,
Gene D Arcy,
Gerald D Bromley, Jr,
Helen B Ricalde,
Humera T Khan,
Jaclyn N Munsch,
James L Finn,
James W Plucinski,
James W Whitney,
Jamie P Webb,
Jan B Welch,
Jason D Abel,
Jason F Chancey,
Jayne E Holcomb,
Jeanne M Morris,
Jennifer S Ness,
Jesse A Vazquez,
Jessica A Stephens,
Joan A Loreng,
John M Seale,
Joseph A Morkunas,
Joshua M Adams,
Julie D Bringger,
Karen Emasley Joseph,
Kathleen B Swat,
Kimberly Lewandowski Walker,
Konsuela Y Glass,
Kujtim Sadiku,
Laiza V Garcia,
Lakisha M Williams,
Laressa R Gray,
Larry F Hallberg,
Lauren A Crivellone,
Laurie A Haxel,
Lee Terry Moore,
Lequita M Mayhew,
Liliya V Bubiy,
Lisa Hayka,
Lisa Hornback,
Lisa M Lopez,
Lorelei S Jarrell,
Maksim A Levenchuk,
Margaret Torres Vazquez,
Maria Diaz,
Marissa S Steinhagen,
Martha T Olone,
Matthew J Sienko,
Matthew T Sanchez,
Maureen C Melvin,
Melissa I Michurski,
Melissa J Holz,
Michael D Robinson,
Naashon Deberry,
Natasha R Johnson,
Nicholas F Lyons,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole J Clausen,
Nicole K Trudel,
Nicole S Williams,
Norman L Brown,
Norman Wong,
Omotunde O Osunsanmi,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Patrick E Gainer,
Paul E Stein,
Paula P Demichael,
Phung Thien Nguyen,
Prabhu P Raju,
Rachel T Evans,
Rafael A Kaup,
Rafael Padilla,
Renee L Anderson,
Richard J Bashay,
Richard Jay Tucker, RS,
Robert L Stevenson,
Roberta W Cunningham,
Roy Baby,
Russell K Riley,
Samuel W Labinjo,
Sarah B Tanksley,
Seema S Singh,
Shafiq S Ahadi,
Stefen D Mcmillan,
Stephen D Eich,
Sullan,
Susan A Zullo, PhD,
Susan M Jackson,
Tamara Brey,
That Q Dang,
Thomas W Garvin,
Todd M Stankewicz,
Todd Q Dang,
Wanda B Coats,
Whitney M White,
William R Weissinger,
Yvonne E Lozano
Amanda Dinaro's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more